Defective Fibrin Crosslinking in Acute Leukemia

Summary

Fibrin crosslinking was assayed in 22 patients with acute leukemia showing secondary coagulation abnormalities of variable severity. In 9 patients fibrin crosslinking was found to be normal, whereas 10 patients presented impaired polymerization of α-chains and 3 of both α- and γ-chains.

Only a rough correlation was found between transamidating activity of factor XIII and the fibrin crosslinking pattern in these patients. Moreover, incomplete fibrin crosslinkage occurred at levels of factor XIII far in excess of that required for full polymerization of fibrin in “normal” plasma. This latter finding suggests that, in addition to factor XIII deficiency, other causes are responsible for thehigh rate of fibrin crosslinking impairment in acute leukemia.

Key words

Factor XIII - Fibrin crosslinking - Acute leukemia - Disseminated intravascular coagulation

• References

• 1 Schwartz ML, Pizzo SU, Hill RL, McKee PA. Human Factor XIII from plasma and platelets. J Biol Chem 1973; 248: 1395-1407
• 2 Chen R, Doolittle RF. Identification of the polypeptide chains involved in the cross-linking of fibrin. Proc Natl Acad Sei USA 1969; 63: 420-427
• 3 McKee PA, Mattock P, Hill RL. Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. Proc Natl Acad Sei USA 1970; 66: 738-744
• 4 Gaffney PJ, Whitaker AN. Fibrin crosslinks and lysis rates. Thromb Res 1979; 14: 85-94
• 5 Shen L, Lorand L. Contribution of fibrin stabilization to clot strength. J Clin Invest 1983; 71: 1336-1341
• 6 Lorand L, Losowski MS, Miloszewski KG M. Human Factor XIII: Fibrin stabilizing factor. In: Progress in Haemostasis and Thrombosis. Spaet TN. (Ed) Grune & Stratton Inc; New York: 1980. 5 245-290
• 7 Barbui T, Rodeghiero F, Dini E. Factor XIII subunits -A and -S in congenital deficiency and in acute myeloblastic leukaemia. Haematologica 1974; 59: 458-466
• 8 Havemann K, Egbring R, Gropp C, Schmidt M, Sodomann CP. Factor-XIII-Mangel bei akuter Leukämie des Erwachsenen. Ergebnisse einer Substitution mit Faktor XIII Klin Wochenschr 1977; 55: 801-809
• 9 Kreissei M, Oehme J. Faktor-XIII-Aktivität im Plasma bei akuter Leukämie im Kindesalter. Klin Paediatr 1973; 185: 267-270
• 10 Rasche M, Dietrich M, Hiemeyer V. Untersuchungen über die Faktor-XIII-Aktivität im Plasma bei akuter Leukämie. Klin Wochenschr 1972; 50: 1017-1019
• 11 Bennet JM, Catowski B, Daniel MT, Flandrin G, Galton DA G, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. Br J Haematol 1976; 33: 451-458
• 12 Rodeghiero F, Barbui T, Dal Belin A. Simplified method for the polyacrilamide gel electrophoresis of fibrin. Giornale Arteriosclerosi 1977; 2: 23-29
• 13 Rodeghiero F, Barbui T. Fibrin cross-linking in congenital factor XIII deficiency. J Clin Pathol 1980; 33: 434-437
• 14 Finlayson GS, Morton RO. Gel electrophoresis for assessing fibrin cross-linking: a precaution. Clin Chim Acta 1972; 36: 254-256
• 15 Barbui T, Rodeghiero F, Dini E, Mariani G, Papa ML, De Biasi R, Cordero Murillo R, Montero Umana C. Subunit -A and -S inheritance in four families with congenital factor XIII deficiency. Br J Haematol 1978; 38: 267-271
• 16 Rodeghiero F, Barbui T, Battista R, Chisesi T, Rigoni E, Dini E. Molecular subunits and transamidase activity of factor XIII during disseminated intravascular coagulation in acute leukaemia. Thromb Haemostas 1980; 43: 6-9
• 17 Egbring R, Schmidt W, Fuchs G, Havemann K. Demonstration of granulocyte proteases in plasma of patients with acute leukaemia and septicaemia with coagulation defects. Blood 1977; 49: 219-231
• 18 Rasche M, Dietrich M, Gaus W, Schleyer M. Factor-XIII-activity and fibrin structure in acute leukaemia. Biomedicine 1974; 21: 61-66
• 19 Bohn M. Immunologische Untersuchungen über Faktor XIII und das FSF-bindende Globulin. Blut 1974; 28: 81-89
• 20 Rodeghiero F, Morbin M, Barbui T. Subunit A of factor XIII regulates subunit B plasma concentration. Thromb Haemostas 1981; 46: 621-622
• 21 Niewiarowski S, Stewart GJ, Marder VJ. Formation of highly ordered polymers from fibrinogen and fibrin degradation products. Biochim Biophys Acta 1970; 221: 326-341
• 22 Schwartz ML, Pizzo SU, Hill RL, McKee PA. The effect of fibrin stabilizing factor on the subunit structure of human fibrin. J Clin Invest 1971; 50: 1506-1513
• 23 Duckert F. Documentation of the plasma factor XIII deficiency in man. Ann NY Acad Sei 1972; 202: 190-199
• 24 Lisiewicz G. Mechanisms of hemorrage in leukemias. Semin Thromb Haemostas 1978; 4: 241-267
• 25 Mosesson MW, Finlayson JS, Umfleet RA, Galanakis D. Human fibrinogen heterogeneties. 1.Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates. J Biol Chem 1972; 247: 5210-5219